Mustang Bio Inc (MBIO)
0.1885
-0.02
(-10.20%)
USD |
NASDAQ |
May 28, 16:00
0.201
+0.01
(+6.63%)
After-Hours: 06:43
Mustang Bio Cash from Operations (Quarterly): -5.321M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -5.321M |
| December 31, 2023 | -7.254M |
| September 30, 2023 | -12.02M |
| June 30, 2023 | -12.39M |
| March 31, 2023 | -17.81M |
| December 31, 2022 | -15.29M |
| September 30, 2022 | -15.91M |
| June 30, 2022 | -17.58M |
| March 31, 2022 | -16.29M |
| December 31, 2021 | -14.70M |
| September 30, 2021 | -11.29M |
| June 30, 2021 | -12.10M |
| March 31, 2021 | -15.58M |
| December 31, 2020 | -9.475M |
| September 30, 2020 | -10.12M |
| June 30, 2020 | -7.568M |
| March 31, 2020 | -10.15M |
| Date | Value |
|---|---|
| December 31, 2019 | -9.49M |
| September 30, 2019 | -8.83M |
| June 30, 2019 | -8.778M |
| March 31, 2019 | -6.483M |
| December 31, 2018 | -6.523M |
| September 30, 2018 | -3.80M |
| June 30, 2018 | -3.356M |
| March 31, 2018 | -5.565M |
| December 31, 2017 | -5.167M |
| September 30, 2017 | -4.771M |
| June 30, 2017 | -0.974M |
| March 31, 2017 | -2.036M |
| December 31, 2016 | -2.263M |
| September 30, 2016 | -0.565M |
| June 30, 2016 | -0.72M |
| March 31, 2016 | -0.581M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-17.81M
Minimum
Mar 2023
-5.321M
Maximum
Mar 2024
-11.90M
Average
-11.66M
Median
Cash from Operations (Quarterly) Benchmarks
| Fortress Biotech Inc | -25.39M |
| Avinger Inc | -4.734M |
| AIM ImmunoTech Inc | -4.815M |
| Protalix BioTherapeutics Inc | 4.188M |
| Armata Pharmaceuticals Inc | -10.58M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 0.049M |
| Free Cash Flow | -36.99M |
| Free Cash Flow Per Share (Quarterly) | -0.4728 |
| Free Cash Flow Yield | -2.09K% |